Macroeconomic Impact of HIV/AIDS in the Asian and Pacific Region. Tandon, A (2005)

Macroeconomic Impact of HIV/AIDS in the Asian and Pacific Region. Tandon, A (2005) Widespread prevalence of diseases such as Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome or HIV/AIDS, malaria, and tuberculosis are a significant constraint to development in low- and middle-income countries. The impact of HIV/AIDS has been especially devastating in sub-Saharan Africa where some countries are now seeing declines in life expectancy of up to 20 years as a result of the disease taking on pandemic proportions in the continent. Globally, HIV/AIDS is now the leading cause of adult mortality (WHO 2004). In 2004, an estimated 4.9 million deaths worldwide were attributable to HIV/AIDS (UNAIDS and WHO 2004). Given an average lag of 10 years between infection and death, the morbidity effects for an estimated 39.4 million people now living with HIV/AIDS are also substantial.

Download this publication

Country Report on National AIDS Spending Assessment (NASA) Year 2000-2004 in Lao PDR. Ministry of Health Department of Hygiene and Epidemiology Center for HIV/AIDS/STI. (2005)

immage

The National AIDS Spending Assessment aims to assess the situation of the actual National expenditures on HIV/AIDS activities over the last five years (2000-2004) from different institutions. The total AIDS expenditure over the past five years is estimated at Lao Kip 148.62 billion (USD 14.85 million). The expenditure trend has shown the steadily increase steadily every year from 2.1 million in 2000 to 4.99 million in 2004. There were two sources of National AIDS Spending, from the government (in kind see table 2), and from external assistant. Remarkably, a large spending of AIDS came from external sources of 98.83 percent to 99.83 percent.

 

Download Publication

Economic and Social Progress in Jeopardy: HIV/AIDS in the Asian and Pacific Region. ESCAP (2003)

Economic and Social Progress in Jeopardy: HIV/AIDS in the Asian and Pacific Region. ESCAP (2003) At its first opportunity following the United Nations General Assembly special session on HIV/AIDS, the Commission, at its fifty-eighth session in April 2002, adopted as its theme topic for the fifty-ninth session “Integrating economic and social concerns, especially HIV/AIDS, in meeting the needs of the region”.

Download this publication

Counselling and Voluntary HIV Testing for Pregnant Women in High HIV Prevalence Countries: Elements and Issues. UNAIDS (2001)

Counselling and Voluntary HIV Testing for Pregnant Women in High HIV Prevalence Countries: Elements and Issues. UNAIDS (2001) Cost-effectiveness analysis is a tool which enables programme managers and planners dealing with HIV/AIDS to make informed decisions about resource allocation. By measuring and comparing the costs and consequences of various interventions, their relative efficiency can be assessed and future resource requirements estimated.

Download this publication

Costing Guidelines for HIV Prevention Strategies 2000. UNAIDS (2000)

Costing Guidelines for HIV Prevention Strategies 2000. UNAIDS (2000) In order to conduct a cost analysis of a project or programme, it is crucial to understand how a project functions. This section provides an introduction to dif- ferent HIV prevention strategies and highlights factors that are important to the collection of the cost data. Under the heading of established strategies, exam- ples of nine strategies are presented.

Download this publication

Funding Priorities for the HIV/AIDS Crisis in Thailand. UNAIDS (1999)

Funding Priorities for the HIV/AIDS Crisis in Thailand. UNAIDS (1999) This paper introduces the conceptual framework of interrelated consequences of the economic crisis on HIV/AIDS pre- vention and control. On the basis of docu- ment research and in-depth interviews with officials at national and provincial levels, we explain how the Government of Thailand has dealt with the AIDS epi- demic during the period of economic hardship. The paper describes how programme managers at national and pro- vincial levels have responded to budget cuts and discusses the impact the cuts may have on the effectiveness of programmes. The state of government finance and agree- ments with the International Monetary Fund have led to many policy adjustments and budget amendments.

Download this publication

Thailand National AIDS Spending Assessment Assessment 2000-2004. Tisayaticom K, Chokchaichan H, Teokul W, et al (no date)

Thailand National AIDS Spending Assessment Assessment 2000-2004. Tisayaticom K, Chokchaichan H, Teokul W, et al (no date) HIV/AIDS spending in Thailand was 4,943.32 millions baht (122.90 million USD) in 2004, nearly doubled from that of 2,623.27 millions baht (65.4 million USD) in 2000. HIV/AIDS spending per capita increased from 1.05 USD in 2000 to 1.91 USD in 2004 while expenditure per capita PLWA increased dramatically 2.3 times from 94.19 USD in 2000 to 214.68 USD in 2004. In addition, the share of HIV/AIDS expenditure to total health expenditure (THE) increased from 1.57% in 2000 to 2.64% in 2004.

Download this publication

Donor Funding for Health in Low - & Middle - Income Countries, 2002-2010. Wexler A, Valentine A, and Kates J. (2013)

immage

Trends between 2002 and 2010 provide an indication of donor priorities and important shifts. For instance, the U.S. remained the largest donor to health in each year over the period and provided the greatest share of its ODA for health. Additionally, the donor mix has shifted over time, in part due to the entrance of new donors, particularly the Global Fund, which was created in 2002 and has been the second largest donor since 2006. The U.S. and the Global Fund combined accounted for more than half of total donor funding for health in 2010.

Download Publication

Donor Funding for Health in Low - & Middle - Income Countries, 2002-2010. Wexler A, Valentine A, and Kates J. (2013)

immage

Trends between 2002 and 2010 provide an indication of donor priorities and important shifts. For instance, the U.S. remained the largest donor to health in each year over the period and provided the greatest share of its ODA for health. Additionally, the donor mix has shifted over time, in part due to the entrance of new donors, particularly the Global Fund, which was created in 2002 and has been the second largest donor since 2006. The U.S. and the Global Fund combined accounted for more than half of total donor funding for health in 2010.

Download Publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NEC_HIV_May-AIDSreg2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Biomedical_AIDS_research_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Factsheets.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Integrating_collaborative_TB_and_HIV_services_within_a_comprehensive_package_of_care_for_PWID_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_IBBS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_HSS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_young_people_drugs_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Transforming_our_world_2015_UN.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Oct
11
Nov
14
Nov
20